References

• 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
• 1998Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings658 cited
• 2001Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons251 cited
• 2002The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats221 cited
• 2003Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users190 cited
• 20013,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose185 cited
• 1987Differences in the central serotonergic effects of Methylenedioxymethamphetamine (MDMA) in mice and rats131 cited
• 1988Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity125 cited
• 2003Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA100 cited
• 1999The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain95 cited
• 1994Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats81 cited

Cited by

No citing works inside the corpus for this window.